ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Sjögren's Syndrome

New Sjogren's Guidelines Outline 19 Treatment Recommendations

The first-ever treatment guidelines for Sjogren's syndrome have been issued. They include the use of rituximab for oral dryness, but a new U.K. study disputes this use for rituximab. (©WerayuthTes/Shutterstock.com)

Sjögren's Syndrome

The first-ever treatment guidelines for systemic Sjogren’s syndrome have been issued highlighting the need to alleviate symptoms, improve quality of life and prevent further damage.

©AndreyPopov/Shutterstock.com

The American College of Rheumatology and the European League Against Rheumatism have published an international set of classification criteria for primary Sjögren's syndrome.

©PhuShutter/Shutterstock.com

The Rheumatology Journal Club resumes its Twitter chat series this week with a focus on rheumatological immune-related adverse events in immunotherapy.

©AndreyPopov/Shutterstock.com

Clinicians should pay more attention to neurological signs in patients with high-activity primary Sjogren’s Syndrome or those with prior neurological involvements.

©vitstudio/Shuttersstock.com

Autoantibodies against carbamylated proteins in Sjögren’s syndrome could be used as a new biomarker.

B-cells that are active in lupus may also play a role in Sjögren’s syndrome. A new study finds that the same B-cell depleter drug, belimumab (Benlysta) approved for lupus, may also benefit Sjögren’s patients.

Pages

Subscribe to Sjögren's Syndrome on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.